在糖尿病病中准补充C5a受体的治疗潜力
Inez A Trambas1, Melinda T Coughlan1, Sih Min Tan1
1Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC 3004, Australia.
糖尿病病涉及补体系统的激活. 准C5a受体通路可能通过减少炎症和纤维化来保护脏.
科学领域:
- 免疫学 免疫学 免疫学
- 腎臟病學 (nephrology) 是一種醫學.
- 内分泌学 在内分泌学.
背景情况:
- 糖尿病病 (DKD) 影响30%-40%的糖尿病患者,导致末期病 (ESRD).
- 补充级联激活,特别是C5a信号轴,在DKD中驱动炎症,线粒体功能障碍和氧化应激.
- 目前的糖尿病治疗不针对补体系统,突出显示了治疗缺口.
研究的目的:
- 审查C5a/C5a受体轴在糖尿病损伤病原发生中的作用.
- 为DKD提供针对这一轴的补充疗法概述.
主要方法:
- 临床前和临床研究的文献综述.
- 在DKD中分析C5a受体信号传递的机制.
- 在开发过程中对补充疗法的评估.
主要成果:
- C5a受体轴在DKD中促进炎症和纤维化.
- 抑制C5a受体信号传递可以减少炎症,同时保持重要的免疫功能.
- 临床前数据表明补充剂抑制在DKD中具有保护作用.
结论:
- C5a/C5a受体轴是DKD的一个关键驱动器.
- 准C5a受体信号传导是DKD的一个有前途的治疗策略.
- 补充剂抑制剂的进一步开发对于DKD治疗是有必要的.
更多相关视频
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
16:26Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
相关概念视频
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Acute Kidney Injury II: Pathophysiology
